retatrutide phase 2 nejm weight loss 48 weeks percent Why do so many people ignore the dosing regimen described in the Trial? : r/Retatrutide retatrutide nejm 2023 Triple hormone receptor agonist retatrutide

Conclusion With continuous breakthroughs in oral GLP-1 therapies, oral GLP-1 drug development trends are driving a new growth cycle in the global metabolic disease treatment landscape

Specifically, the Senate hearings where pharmaceutical CEOs and PBM executives sat across from Bernie Sanders and everyone yelled at each other for three hours and absolutely nothing changed

Semaglutide 2.4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomized, double-blind, double-dummy, placebo-controlled, phase 3 trial

British Columbia, Alberta, Saskatchewan, Manitoba, Ontario, Quebec, and Atlantic provinces generally cover GLP-1 medications only for diabetes indications

Unlock Your Best Self

A 180-degree turnaround in thinking There is a pernicious perception that GLP-1s are a way for the lazy and/or rich to cheat at weight loss